Searcharxiv⌕ Search

arXiv subjects

Jean-Claude M. Rwigema

Publications and source records attributed to Jean-Claude M. Rwigema.

6 recordsLinked to original sources

A Multimodal Clinically Informed Coarse-to-Fine Framework for Longitudinal CT Registration in Proton Therapy

Proton therapy offers superior organ-at-risk sparing but is highly sensitive to anatomical changes, making accurate deformable image registration (DIR) across longitudinal CT scans essential. Conventional DIR methods are often too slow for emerging online adaptive workflows, while existing deep learning-based approaches are primarily designed for generic benchmarks and underutilize clinically relevant information beyond images. To address this gap, we propose a clinically scalable coarse-to-fine deformable registration framework that integrates multimodal information from the proton radiotherapy workflow to accommodate diverse clinical scenarios. The model employs dual CNN-based encoders for hierarchical feature extraction and a transformer-based decoder to progressively refine deformation fields. Beyond CT intensities, clinically critical priors, including target and organ-at-risk contours, dose distributions, and treatment planning text, are incorporated through anatomy- and risk-guided attention, text-conditioned feature modulation, and foreground-aware optimization, enabling anatomically focused and clinically informed deformation estimation. We evaluate the proposed framework on a large-scale proton therapy DIR dataset comprising 1,222 paired planning and repeat CT scans across multiple anatomical regions and disease types. Extensive experiments demonstrate consistent improvements over state-of-the-art methods, enabling fast and robust clinically meaningful registration.

cs.CV↗

An Automated Retrieval-Augmented Generation LLaMA-4 109B-based System for Evaluating Radiotherapy Treatment Plans

Purpose: To develop a retrieval-augmented generation (RAG) system powered by LLaMA-4 109B for automated, protocol-aware, and interpretable evaluation of radiotherapy treatment plans. Methods and Materials: We curated a multi-protocol dataset of 614 radiotherapy plans across four disease sites and constructed a knowledge base containing normalized dose metrics and protocol-defined constraints. The RAG system integrates three core modules: a retrieval engine optimized across five SentenceTransformer backbones, a percentile prediction component based on cohort similarity, and a clinical constraint checker. These tools are directed by a large language model (LLM) using a multi-step prompt-driven reasoning pipeline to produce concise, grounded evaluations. Results: Retrieval hyperparameters were optimized using Gaussian Process on a scalarized loss function combining root mean squared error (RMSE), mean absolute error (MAE), and clinically motivated accuracy thresholds. The best configuration, based on all-MiniLM-L6-v2, achieved perfect nearest-neighbor accuracy within a 5-percentile-point margin and a sub-2pt MAE. When tested end-to-end, the RAG system achieved 100% agreement with the computed values by standalone retrieval and constraint-checking modules on both percentile estimates and constraint identification, confirming reliable execution of all retrieval, prediction and checking steps. Conclusion: Our findings highlight the feasibility of combining structured population-based scoring with modular tool-augmented reasoning for transparent, scalable plan evaluation in radiation therapy. The system offers traceable outputs, minimizes hallucination, and demonstrates robustness across protocols. Future directions include clinician-led validation, and improved domain-adapted retrieval models to enhance real-world integration.

cs.AI↗

Diffusion Transformer-based Universal Dose Denoising for Pencil Beam Scanning Proton Therapy

Purpose: Intensity-modulated proton therapy (IMPT) offers precise tumor coverage while sparing organs at risk (OARs) in head and neck (H&N) cancer. However, its sensitivity to anatomical changes requires frequent adaptation through online adaptive radiation therapy (oART), which depends on fast, accurate dose calculation via Monte Carlo (MC) simulations. Reducing particle count accelerates MC but degrades accuracy. To address this, denoising low-statistics MC dose maps is proposed to enable fast, high-quality dose generation. Methods: We developed a diffusion transformer-based denoising framework. IMPT plans and 3D CT images from 80 H&N patients were used to generate noisy and high-statistics dose maps using MCsquare (1 min and 10 min per plan, respectively). Data were standardized into uniform chunks with zero-padding, normalized, and transformed into quasi-Gaussian distributions. Testing was done on 10 H&N, 10 lung, 10 breast, and 10 prostate cancer cases, preprocessed identically. The model was trained with noisy dose maps and CT images as input and high-statistics dose maps as ground truth, using a combined loss of mean square error (MSE), residual loss, and regional MAE (focusing on top/bottom 10% dose voxels). Performance was assessed via MAE, 3D Gamma passing rate, and DVH indices. Results: The model achieved MAEs of 0.195 (H&N), 0.120 (lung), 0.172 (breast), and 0.376 Gy[RBE] (prostate). 3D Gamma passing rates exceeded 92% (3%/2mm) across all sites. DVH indices for clinical target volumes (CTVs) and OARs closely matched the ground truth. Conclusion: A diffusion transformer-based denoising framework was developed and, though trained only on H&N data, generalizes well across multiple disease sites.

physics.med-ph↗

Robust Optimization for Spot Scanning Proton Therapy based on Dose-Linear Energy Transfer (LET) Volume Constraints

Purpose: Historically, spot scanning proton therapy (SSPT) treatment planning utilizes dose volume constraints and linear-energy-transfer (LET) volume constraints separately to balance tumor control and organs-at-risk (OARs) protection. We propose a novel dose-LET volume constraint (DLVC)-based robust optimization (DLVCRO) method for SSPT in treating prostate cancer to obtain a desirable joint dose and LET distribution to minimize adverse events (AEs). Methods: DLVCRO treats DLVC as soft constraints controlling the joint distribution of dose and LET. Ten prostate cancer patients were included with rectum and bladder as OARs. DLVCRO was compared with the conventional robust optimization (RO) method using the worst-case analysis method. Besides the dose-volume histogram (DVH) indices, the analogous LETVH and extra-biological-dose (xBD)-volume histogram indices were also used. The Wilcoxon signed rank test was used to measure statistical significance. Results: In nominal scenario, DLVCRO significantly improved dose, LET and xBD distributions to protect OARs (rectum: V70Gy: 3.07\% vs. 2.90\%, p = .0063, RO vs. DLVCRO; $\text{LET}_{\max}$ (keV/um): 11.53 vs. 9.44, p = .0101; $\text{xBD}_{\max}$ (Gy$\cdot$keV/um): 420.55 vs. 398.79, p = .0086; bladder: V65Gy: 4.82\% vs. 4.61\%, p = .0032; $\text{LET}_{\max}$ 8.97 vs. 7.51, p = .0047; $\text{xBD}_{\max}$ 490.11 vs. 476.71, p = .0641). The physical dose distributions in targets are comparable (D2%: 98.57\% vs. 98.39\%; p = .0805; CTV D2% - D98%: 7.10\% vs. 7.75\%, p = .4624). In the worst-case scenario, DLVCRO robustly enhanced OAR while maintaining the similar plan robustness in target dose coverage and homogeneity. Conclusion: DLVCRO upgrades 2D DVH-based to 3D DLVH-based treatment planning to adjust dose/LET distributions simultaneously and robustly. DLVCRO is potentially a powerful tool to improve patient outcomes in SSPT.

physics.med-ph↗

Accurate Patient Alignment without Unnecessary Imaging Dose via Synthesizing Patient-specific 3D CT Images from 2D kV Images

In radiotherapy, 2D orthogonally projected kV images are used for patient alignment when 3D-on-board imaging(OBI) unavailable. But tumor visibility is constrained due to the projection of patient's anatomy onto a 2D plane, potentially leading to substantial setup errors. In treatment room with 3D-OBI such as cone beam CT(CBCT), the field of view(FOV) of CBCT is limited with unnecessarily high imaging dose, thus unfavorable for pediatric patients. A solution to this dilemma is to reconstruct 3D CT from kV images obtained at the treatment position. Here, we propose a dual-models framework built with hierarchical ViT blocks. Unlike a proof-of-concept approach, our framework considers kV images as the solo input and can synthesize accurate, full-size 3D CT in real time(within milliseconds). We demonstrate the feasibility of the proposed approach on 10 patients with head and neck (H&N) cancer using image quality(MAE: <45HU), dosimetrical accuracy(Gamma passing rate (2%/2mm/10%)>97%) and patient position uncertainty(shift error: <0.4mm). The proposed framework can generate accurate 3D CT faithfully mirroring real-time patient position, thus significantly improving patient setup accuracy, keeping imaging dose minimum, and maintaining treatment veracity.

eess.SP↗

Artificial Intelligence-Facilitated Online Adaptive Proton Therapy Using Pencil Beam Scanning Proton Therapy

We propose an oAPT workflow that incorporates all these functionalities and validate its clinical implementation feasibility with prostate patients. AI-based auto-segmentation tool AccuContourTM (Manteia, Xiamen, China) was seamlessly integrated into oAPT. Initial spot arrangement tool on the vCT for re-optimization was implemented using raytracing. An LET-based biological effect evaluation tool was developed to assess the overlap region of high dose and high LET in selected OARs. Eleven prostate cancer patients were retrospectively selected to verify the efficacy and efficiency of the proposed oAPT workflow. The time cost of each component in the workflow was recorded for analysis. The verification plan showed significant degradation of the CTV coverage and rectum and bladder sparing due to the interfractional anatomical changes. Re-optimization on the vCT resulted in great improvement of the plan quality. No overlap regions of high dose and high LET distributions were observed in bladder or rectum in re-plans. 3D Gamma analyses in PSQA confirmed the accuracy of the re-plan doses before delivery (Gamma passing rate = 99.57%), and after delivery (98.59%). The robustness of the re-plans passed all clinical requirements. The average time for the complete execution of the workflow was 9.12minutes, excluding manual intervention time. The AI-facilitated oAPT workflow was demonstrated to be both efficient and effective by generating a re-plan that significantly improved the plan quality in prostate cancer treated with PBSPT.

physics.med-ph↗